Strain Information | |
---|---|
Image | |
BRC No. | RBRC02385 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129-Rps6kb1<tm1Nte> |
Former Common name | p70s6 Knockout mice |
H-2 Haplotype | |
ES Cell line | R1 [(129X1/SvJ x 129S1/Sv)F1-Kitl<+>] |
Background strain | C57BL/6NCrlCrlj |
Appearance | |
Strain development | Developed by Hideki Kawasome, Natonal Jewish Medical and Research Center in 1997. |
Strain description | Homozygous mutant mice are small. |
Colony maintenance | |
References | Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Kawasome H, Papst P, Webb S, Keller G M, Johnson G L, Gelfand E W, Terada N Proc. Natl. Acad. Sci. USA, 95, 5033-5038 (1998). 9560223 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Rps6kb1 MGI:1270849 | ribosomal protein S6 kinase, polypeptide 1 | 11 | Rps6kb1<tm1Nte> | targeted mutation 1, Naohiro Terada | |||
neo | neomycin resistance gene (E. coli) | 11 | herpes simplex virus thymidine kinase promoter (HSV tk promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 7 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | herpes simplex virus thymidine kinase promoter (HSV tk promoter), E. coli neo, mouse Rps6kb1 genomic DNA |
Research application | Cell Biology Research |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Use of the BIOLOGICAL RESOURCE or descendants by for-profit entities for Commercial Purposes requires a use license from DEPOSITOR. RIKEN BRC agrees to inquire whether the party requesting the BIOLOGICAL RESOURCE is a for-profit entity or is using the BIOLOGICAL RESOURCE of descendants for Commercial Purposes, and if so, will advise the party that it must first obtain a use license from DEPOSITOR before receiving the BIOLOGICAL RESOURCE. Commercial Purposes shall include, but not be limited to, uses of the BIOLOGICAL RESOURCE of descendants by any organization, including recipient, to perform contract research, to screen compound libraries, to produce or manufacture products for general sale, or to conduct research activities that result in any sale, lease, license, or transfer of industrially sponsored academic research shall not be considered a use of the BIOLOGICAL RESOURCE for Commercial Purposes per se, unless any of the above conditions of this definition are met. |
Depositor | Erwin W. Gelfand (National Jewish Medical and Research Center) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
Zhao J, Li SW, Gong QQ, Ding LC, Jin YC, Zhang J, Gao JG, Sun XY. A disputed evidence on obesity: comparison of the effects of Rcan2(-/-) and Rps6kb1(-/-) mutations on growth and body weight in C57BL/6J mice. J Zhejiang Univ Sci B 17(9) 657-71(2016) 27604858 |